Cost Effectiveness of Sorafenib for Treatment of Advanced Hepatocellular Carcinoma in India
ConclusionsSorafenib is not cost-effective for use in advanced hepatocellular carcinoma treatment in India.
Source: Journal of Clinical and Experimental Hepatology - Category: Gastroenterology Source Type: research
More News: Cancer & Oncology | Carcinoma | Gastroenterology | Hepatocellular Carcinoma | India Health | Liver Cancer | Study